is cancer vaccine treatment worth the cost?, page-17

Mj
I must confess to being a bit nervous myself about the economic situations in the US and Europe.

PRR went through a near death experience during the GFC. Had it not been for Lucy Turnbull's cash PRR would have foundered and the IP would have been sold off for peanuts to one of the big pharmas. As it was, PRR had to raise capital at rediculously low prices and do a deal with the devil (Springtree) which caused massive dilution. A necessary evil in retrospect. That battle for survival caused a significant slow down of the strategic timeframes and my guess would be that PRR probably lost about 12 months of progress.

Fortunately the picture is very different now. This CR places the company in a secure financial position for the 2.5-3 year timeframe to complete trials and FDA/EU approvals. Meantime we have imminent pilot income streams from Dubai and potentially other jurisdictions (tip..Aust next).

Another global recession will not impact on PRR's trials program or require further equity requirements & share dilution.

As I have a long term investment strategy for PRR, it doesn't really matter to me what happens to the SP in the meantime.

But I will be stocking up on tinned meat, toilet paper and ammunition. LOL